Related Experiment Video
Updated: Aug 13, 2025

Lentiviral Mediated Gene Silencing in Human Pseudoislet Prepared in Low Attachment Plates
Published on: May 14, 2019
Type 2 diabetes candidate genes, including PAX5, cause impaired insulin secretion in human pancreatic islets
Karl Bacos1, Alexander Perfilyev1, Alexandros Karagiannopoulos2
1Epigenetics and Diabetes Unit, Department of Clinical Sciences and.
Abstract:
Type 2 diabetes (T2D) is caused by insufficient insulin secretion from pancreatic β cells. To identify candidate genes contributing to T2D pathophysiology, we studied human pancreatic islets from approximately 300 individuals. We found 395 differentially expressed genes (DEGs) in islets from individuals with T2D, including, to our knowledge, novel (OPRD1, PAX5, TET1) and previously identified (CHL1, GLRA1, IAPP) candidates. A third of the identified expression changes in islets may predispose to diabetes, as expression of these genes associated with HbA1c in individuals not previously diagnosed with T2D. Most DEGs were expressed in human β cells, based on single-cell RNA-Seq data. Additionally, DEGs displayed alterations in open chromatin and associated with T2D SNPs. Mouse KO strains demonstrated that the identified T2D-associated candidate genes regulate glucose homeostasis and body composition in vivo. Functional validation showed that mimicking T2D-associated changes for OPRD1, PAX5, and SLC2A2 impaired insulin secretion. Impairments in Pax5-overexpressing β cells were due to severe mitochondrial dysfunction. Finally, we discovered PAX5 as a potential transcriptional regulator of many T2D-associated DEGs in human islets. Overall, we have identified molecular alterations in human pancreatic islets that contribute to β cell dysfunction in T2D pathophysiology.
Insights
Researchers identified 395 genes with altered expression in pancreatic islets of individuals with type 2 diabetes (T2D). These gene expression changes contribute to beta cell dysfunction and T2D development.
Area of Science:
- Endocrinology
- Genetics
- Molecular Biology
Background:
- Type 2 diabetes (T2D) is characterized by impaired insulin secretion from pancreatic beta cells.
- Identifying genetic factors influencing T2D pathophysiology is crucial for understanding disease mechanisms.
Purpose of the Study:
- To identify novel candidate genes involved in T2D pathophysiology by analyzing gene expression in human pancreatic islets.
- To investigate the functional relevance of identified genes in beta cell function and glucose homeostasis.
Main Methods:
- Differential gene expression analysis in human pancreatic islets from ~300 individuals (T2D vs. non-diabetic).
- Single-cell RNA-sequencing to determine gene expression in human beta cells.
- Chromatin accessibility assays and association analysis with T2D single nucleotide polymorphisms (SNPs).
- In vivo studies using mouse knockout models and functional validation of candidate genes (OPRD1, PAX5, SLC2A2) in beta cells.
Main Results:
- 395 differentially expressed genes (DEGs) identified in T2D islets, including novel candidates (OPRD1, PAX5, TET1).
- One-third of DEGs associated with HbA1c levels in individuals without diagnosed T2D, suggesting a predisposing role.
- DEGs showed altered chromatin accessibility and association with T2D SNPs.
- Mouse models confirmed the role of candidate genes in glucose homeostasis and body composition.
- Functional studies revealed that altered OPRD1, PAX5, and SLC2A2 expression impairs insulin secretion, with PAX5-related impairment linked to mitochondrial dysfunction.
- PAX5 identified as a potential transcriptional regulator of T2D-associated DEGs.
Conclusions:
- Significant molecular alterations in human pancreatic islets contribute to beta cell dysfunction in T2D.
- Identified DEGs, including novel candidates like PAX5, represent potential therapeutic targets for T2D.
- PAX5 plays a critical role in beta cell function and may regulate multiple T2D-associated genes.
Related Concept Videos
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Insulin Secretory Vesicles
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Cell Specific Gene Expression
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational

